Suppression of spermatogenesis by testosterone enanthate in Thai men

Journal of the Medical Association of Thailand

Volumn 79, Issue 10, 1996, Pages

  Aribarg, Anek ^a   Sukcharoen, Nares ^a   Chanprasit, Yenchit ^a   Ngeamvijawat, Juraporn ^a   Kriangsinyos, Rosarin ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 18244425889     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Rowley MJ, Heller CG. Summary of studies utilizing androgens in the normal human male. In: Patanelli DJ, ed. Hormonal Control of Male Fertility. US Department of Health, Education and Welfare, Publication No. (NIH) 78-1097, 1978: 145-66.
2. Paulsen CA, Leonard JM, Burgess EC, Ospina LF. Male contraceptive development: re-examination of testosterone enanthate as an effective single agent. In: Patanelli DJ, ed. Hormonal Control of Male Fertility. US Department of Health, Education and Welfare, Publication No. (NIH) 78-1097, 1978: 17-36.
3. Swerdloff RS, Palacios A, McClure RD, Campfield RD, Brosman SA. Clinical evaluation of testosterone in the reversible suppression of spermatogenesis in the human male : efficacy, mechanism of action and adverse effects. In: Patanelli DJ, ed. Hormonal Control of Male Fertility. US Department of Helath, Education and Welfare, Publication No (NIH) 78-1097, 1978: 41-63.
4. Schearer SB, Alvarez-Sanchez F, Anselmo J, et al. Hormonal contraception for men. In: Endocrine Approach to Male Contraception. Copenhagen : Scriptor, 1978, pp. 680-712.
5. World Health Organisation Task Force in Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 1990; 336: 955-9.
6. Pangkahila W. Reversible azoospermia induced by an androgen-progestagen combination regimen in Indonesian men. Int J Androl 1991; 44: 248-56.
7. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Comparison of two androgens plus depot medroxyprogesterone acetate for suppression to azoospermia in Indonesian men. Fertil Steril 1993; 60: 1062-8.
8. Reddy PPK, Rao JM. Reversible antifertility action of testosterone propionate in human males. Contraception 1972; 5: 295-301.
9. World Health Organization. Laboratory Manual for the Examination of Human Semen and Semen - Cervical Mucus Interaction. 3rd edition Cambridge: Cambridge University Press, 1992.
10. Sufi SB, Donaldson A, Jeffcoate SL. Programme for the provision of matched assay reagents for the radioimmunoassays. Method manual. 10th edition Geneva : World Health Organization, 1986.
11. du Bois D, du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-71.
12. Knuth UA, Nieschlag E. Endocrine approaches to male fertility control. Baillieres Clin Endocrinol Metab 1987; 1: 113-32.
13. Matsumoto AM. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating-hormone, and sperm production. J Clin Enodocrinol Metab 1990; 71: 216-22.
14. Clermont Y. Kinetics of spermatogenesis in mammals: seminiferous epithelium cycle and spermatogonial renewal. Physiol Rev 1972; 52: 198-236.
15. Neischlag E, Behre HM, Weinbauer GF. Hormonal male contraception : a real chance? In: Nieschlag E, Habenicht UF, eds. Spermatogenesis, Fertilization, Contraception: Molecular, Cellular and Endocrine Events in Male Reproduction. Springer-Verlag, Berlin 1993, pp. 477-501.
16. Matsumoto AM. Is high dosage testosterone an effective male contraceptive agent? Fertil Steril 1988; 50: 324-8.
17. Wu FCW, Aitken RJ. Suppression of sperm function by medroxy-progesterone acetate and testosterone enanthate in steroid male contraception. Fertil Steril 1989; 51: 691-8.